⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL712220 | 0.90 | MAPK1 (0.32) | — | |
| SCHEMBL254457 | 0.84 | — | — | |
| SCHEMBL712577 | 0.84 | EPHX1 (0.30) | — | |
| SCHEMBL12029062 | 0.82 | CYP4F2 (0.32) | — | |
| SCHEMBL12059903 | 0.80 | CYP4F2 (0.35) | — | |
| SCHEMBL712506 | 0.79 | EPHX1 (0.33) | — | |
| SCHEMBL712104 | 0.77 | — | — | |
| Ethylene Glycol SCHEMBL1876642 | 0.76 | — | — | |
| SCHEMBL714714 | 0.75 | — | — | |
| SCHEMBL713027 | 0.75 | EPHX1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3197470-A | — | — | None | — | — | JP | disclosed |
| US-11834417-B2 | Compositions for the treatment of hypertension and/or fibrosis | VECTUS BIOSYSTEMS LIMITED (AU) | 2023-12-05 | — | — | US | disclosed |
| EP-4247828-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | Institut Pasteur (FR) | 2023-09-27 | — | — | EP | disclosed |
| CN-116601163-A | Protected disaccharides, methods for their preparation, their use in the synthesis of zwitterionic oligosaccharides and conjugates thereof | 巴斯德研究所 | 2023-08-15 | — | — | CN | disclosed |
| CN-116420774-A | Application of low-temperature plasma in preparation of banana slices | 西北农林科技大学 | 2023-07-14 | — | — | CN | disclosed |
| CN-110234631-B | Composition for treating hypertension and/or fibrosis | 维克特斯生物系统有限公司 | 2023-02-28 | — | — | CN | disclosed |
| WO-2022106703-A1 | PROTECTED DISACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE IN THE SYNTHESIS OF ZWITTERIONIC OLIGOSACCHARIDES, AND CONJUGATES THEREOF | INSTITUT PASTEUR (FR) | 2022-05-27 | — | — | WO | disclosed |
| US-20210284612-A1 | Compositions for the Treatment of Hypertension and/or Fibrosis | VECTUS BIOSYSTEMS LIMITED (AU) | 2021-09-16 | — | — | US | disclosed |
| EP-3515895-B1 | IMIDAZOLE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS | VECTUS BIOSYSTEMS LTD (AU) | 2021-08-11 | — | — | EP | disclosed |
| EP-3515895-B1 | IMIDAZOLE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS | VECTUS BIOSYSTEMS LTD (AU) | 2021-08-11 | — | — | EP | disclosed |
| EP-1870409-A1 | BENZIMIDAZOLE COMPOUND | Eisai R&D Management Co., Ltd. (JP) | 2007-12-26 | — | — | EP | disclosed |
| US-20070015782-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-18 | — | — | US | disclosed |
| US-20070015782-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-18 | — | — | US | disclosed |
| US-20070015782-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-18 | — | — | US | disclosed |
| US-20070010542-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-11 | — | — | US | disclosed |
| US-20070010542-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-11 | — | — | US | disclosed |
| US-20070010542-A1 | Benzimidazole compound | EISAI CO., LTD. | 2007-01-11 | — | — | US | disclosed |
| JP-H03197470-A | NEW N-ARYL-2-OXAZOLIDINONE COMPOUND | DELALANDE SA | 1991-08-28 | — | — | JP | disclosed |
| US-4876370-A | 1,3,5-nonatriene derivatives, their preparation and their use | RHONE-POULENC SANTE (FR) | 1989-10-24 | — | — | US | disclosed |
| US-4517197-A | ANTIDEPRESSANTS | DELALANDE S.A. (FR) | 1985-05-14 | — | — | US | disclosed |